DENVER SOLUTIONS, LLC Federal Contracts — Government Award History
Total (All Time)$947,906
Latest FY$366,542
Primary AgencyDepartment of Veterans Affairs
DENVER SOLUTIONS, LLC has received $947,906 in total federal contract awards
across 2 fiscal year(s). ▼ 37.0% vs FY2023 Peak year was FY2023 ($581,364).
Primary awarding agency: Department of Veterans Affairs.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2024 | $366,542 | 3건 | Department of Veterans Affairs | |
| FY2023 | $581,364 | 3건 | Department of Veterans Affairs |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2022-10-01 | Department of Veterans Affairs | $426,961 | DO-LEITERS |
| 2022-05-16 | Department of Veterans Affairs | $350,867 | DO-LEITERS |
| 2020-07-20 | Department of Defense | $250,000 | VARIOUS 503B COMPOUNDED INJECTABLE PHARMACEUTICALS |
| 2024-02-13 | Department of Veterans Affairs | $180,672 | ROPIVACAINE |
| 2023-11-13 | Department of Veterans Affairs | $99,370 | ROPIVACAINE HCI 0.2% (2 MG/ML) (FROM API), 545 ML FILL IN ON-Q AND ON-Q CB006 PA |
| 2021-06-01 | Department of Veterans Affairs | $95,470 | 1. KF9206-CB006: KF9206 – ROPIVACAINE 0.2% 550ML QTY: 200 2. F3113: E |
| 2022-06-01 | Department of Veterans Affairs | $95,470 | STERILE COMPOUND |
| 2023-07-10 | Department of Veterans Affairs | $90,093 | ROPIVICAINCE |
| 2024-02-01 | Department of Veterans Affairs | $86,500 | 503B COMPOUNDING FACILITY PHARMACEUTICALS |
| 2024-10-01 | Department of Veterans Affairs | $86,500 | 503B COMPOUNDING FACILITY PHARMACEUTICALS |
| 2022-11-03 | Department of Veterans Affairs | $64,310 | ROPIVICAINE |
| 2025-10-01 | Department of Veterans Affairs | $48,500 | 503B COMPOUNDING FACILITY PHARMACEUTICALS |